IONIS PHARMACEUT. DL-001 financial statements, including revenue, expenses, profit, and loss
The total revenue of ISI for the last quarter is 110.75 M EUR, and it's 62.39% lower compared to the previous quarter. The net income of Q1 24 is -132.35 M EUR.